Arrowsmith

Recent Finacing

Pre-Series A

Recent Raise

$2M

Arrowsmith develops bacteriophage-based therapeutics to treat drug-resistant and hard-to-treat bacterial infections, operating from SakuLab-Tsukuba in Tsukuba, Ibaraki Prefecture, Japan.

arrowsmith.co.jp